Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine carboxyl methyltransferase 1 pseudogene 1 (LCMT1P1)
- Target
- LCMT1P1
- Molecular classification
- Other, Pseudogene
01
Overview
Leucine carboxyl methyltransferase 1 pseudogene 1 (LCMT1P1) is a human pseudogene and does not code for a functional enzyme, receptor, or transporter. Pseudogenes such as LCMT1P1 are typically non-functional DNA sequences that resemble known protein-coding genes but have lost their capacity to encode active proteins due to genetic mutations or evolutionary changes. LCMT1P1 is related by sequence to the LCMT1 gene, which encodes a methyltransferase involved in methylating the carboxyl terminus of protein phosphatase 2A (PP2A), a key regulator of many cellular processes. However, LCMT1P1 itself does not encode a methyltransferase or participate in drug targeting or cell signaling.
- Other names
- AC133552.2leucine carboxyl methyltransferase 1 pseudogene 1LCMT1 pseudogene 1LCMT1P1
02
Mechanism of action
No mechanism of action; not targeted by drugs
03
Biological functions
Other (Pseudogenes generally do not have biological function unless demonstrated as regulatory non-coding RNAs. There is no evidence LCMT1P1 has a defined biological function)
04
Disease associations
Other (There is no evidence associating LCMT1P1 with disease. The protein-coding LCMT1 gene is implicated in cell cycle control and cancer, but its pseudogene LCMT1P1 does not share these associations)
Beyond the preview
Go deeper on Leucine carboxyl methyltransferase 1 pseudogene 1 (LCMT1P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Leucine carboxyl methyltransferase 1 pseudogene 1 (LCMT1P1).